Decreased expression of the insulin-like growth factor 1 receptor by ribozyme cleavage

Lynn C. Shaw, Aqeela Afzal, Alfred S. Lewin, Adrian M. Timmers, Polyxenie E. Spoerri, Maria B. Grant

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

PURPOSE. Insulin-like growth factor (IGF)-1 and its receptor (IGF-1R) are associated with abnormal retinal neovascularization. Ribozymes were designed that selectively decreased the expression of the IGF-1R and these ribozymes were tested in angiogenesis models in vitro and in vivo. METHODS. Two hammerhead ribozymes were designed that cleave the human IGF-1R mRNA. The ribozymes were cloned into recombinant adeno-associated viral vectors (rAAV). The rAAV constructs were transfected into human retinal endothelial cells (HRECs). IGF-1R mRNA and protein levels were examined and the modified Boyden chamber assay used to examine ribozyme effects on cell migration. These constructs were injected intravitreally into mice to determine the effect of the ribozymes on retinal neovascularization in a mouse model of oxygen-induced retinopathy. RESULTS. Relative quantitative RT-PCR analysis showed that IGF-1R Rz1 reduced IGF-1R mRNA levels by 40% ± 10% (P = 0.003), and Western blot analysis showed a 41% ± 5% (P = 4.6 × 10-5) reduction of IGF-1R protein, confirming that this ribozyme reduces IGF-1R expression. IGF-1R Rz1 also reduced IGF-1-induced cell migration by 90% ± 5% (P = 2.9 × 10-9) showing that IGF-1R Rz1 reduces IGF-1R function in HRECs. IGF-1R Rz1 also reduced the amount of preretinal neovascularization by 65% ± 6% (P = 2.7 × 10-5), as measured by the average number of endothelial preretinal nuclei per section. CONCLUSIONS. These studies demonstrate that the IGF-1R ribozymes are effective at reducing the expression and function of the IGF-1R in vitro and in vivo. Therefore, the IGF-1R ribozymes are an effective method for studying the process of angiogenesis and may ultimately be effective as gene therapy tools for the reduction of pathologic retinal angiogenesis.

Original languageEnglish (US)
Pages (from-to)4105-4113
Number of pages9
JournalInvestigative Ophthalmology and Visual Science
Volume44
Issue number9
DOIs
StatePublished - Sep 1 2003
Externally publishedYes

Fingerprint

Somatomedin Receptors
Catalytic RNA
Somatomedins
Retinal Neovascularization
Messenger RNA
Cell Movement
Endothelial Cells
Pathologic Neovascularization

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Shaw, L. C., Afzal, A., Lewin, A. S., Timmers, A. M., Spoerri, P. E., & Grant, M. B. (2003). Decreased expression of the insulin-like growth factor 1 receptor by ribozyme cleavage. Investigative Ophthalmology and Visual Science, 44(9), 4105-4113. https://doi.org/10.1167/iovs.03-0295

Decreased expression of the insulin-like growth factor 1 receptor by ribozyme cleavage. / Shaw, Lynn C.; Afzal, Aqeela; Lewin, Alfred S.; Timmers, Adrian M.; Spoerri, Polyxenie E.; Grant, Maria B.

In: Investigative Ophthalmology and Visual Science, Vol. 44, No. 9, 01.09.2003, p. 4105-4113.

Research output: Contribution to journalArticle

Shaw, Lynn C. ; Afzal, Aqeela ; Lewin, Alfred S. ; Timmers, Adrian M. ; Spoerri, Polyxenie E. ; Grant, Maria B. / Decreased expression of the insulin-like growth factor 1 receptor by ribozyme cleavage. In: Investigative Ophthalmology and Visual Science. 2003 ; Vol. 44, No. 9. pp. 4105-4113.
@article{3443f40932fe4f6c874d6066b6a284f5,
title = "Decreased expression of the insulin-like growth factor 1 receptor by ribozyme cleavage",
abstract = "PURPOSE. Insulin-like growth factor (IGF)-1 and its receptor (IGF-1R) are associated with abnormal retinal neovascularization. Ribozymes were designed that selectively decreased the expression of the IGF-1R and these ribozymes were tested in angiogenesis models in vitro and in vivo. METHODS. Two hammerhead ribozymes were designed that cleave the human IGF-1R mRNA. The ribozymes were cloned into recombinant adeno-associated viral vectors (rAAV). The rAAV constructs were transfected into human retinal endothelial cells (HRECs). IGF-1R mRNA and protein levels were examined and the modified Boyden chamber assay used to examine ribozyme effects on cell migration. These constructs were injected intravitreally into mice to determine the effect of the ribozymes on retinal neovascularization in a mouse model of oxygen-induced retinopathy. RESULTS. Relative quantitative RT-PCR analysis showed that IGF-1R Rz1 reduced IGF-1R mRNA levels by 40{\%} ± 10{\%} (P = 0.003), and Western blot analysis showed a 41{\%} ± 5{\%} (P = 4.6 × 10-5) reduction of IGF-1R protein, confirming that this ribozyme reduces IGF-1R expression. IGF-1R Rz1 also reduced IGF-1-induced cell migration by 90{\%} ± 5{\%} (P = 2.9 × 10-9) showing that IGF-1R Rz1 reduces IGF-1R function in HRECs. IGF-1R Rz1 also reduced the amount of preretinal neovascularization by 65{\%} ± 6{\%} (P = 2.7 × 10-5), as measured by the average number of endothelial preretinal nuclei per section. CONCLUSIONS. These studies demonstrate that the IGF-1R ribozymes are effective at reducing the expression and function of the IGF-1R in vitro and in vivo. Therefore, the IGF-1R ribozymes are an effective method for studying the process of angiogenesis and may ultimately be effective as gene therapy tools for the reduction of pathologic retinal angiogenesis.",
author = "Shaw, {Lynn C.} and Aqeela Afzal and Lewin, {Alfred S.} and Timmers, {Adrian M.} and Spoerri, {Polyxenie E.} and Grant, {Maria B.}",
year = "2003",
month = "9",
day = "1",
doi = "10.1167/iovs.03-0295",
language = "English (US)",
volume = "44",
pages = "4105--4113",
journal = "Investigative Ophthalmology and Visual Science",
issn = "0146-0404",
publisher = "Association for Research in Vision and Ophthalmology Inc.",
number = "9",

}

TY - JOUR

T1 - Decreased expression of the insulin-like growth factor 1 receptor by ribozyme cleavage

AU - Shaw, Lynn C.

AU - Afzal, Aqeela

AU - Lewin, Alfred S.

AU - Timmers, Adrian M.

AU - Spoerri, Polyxenie E.

AU - Grant, Maria B.

PY - 2003/9/1

Y1 - 2003/9/1

N2 - PURPOSE. Insulin-like growth factor (IGF)-1 and its receptor (IGF-1R) are associated with abnormal retinal neovascularization. Ribozymes were designed that selectively decreased the expression of the IGF-1R and these ribozymes were tested in angiogenesis models in vitro and in vivo. METHODS. Two hammerhead ribozymes were designed that cleave the human IGF-1R mRNA. The ribozymes were cloned into recombinant adeno-associated viral vectors (rAAV). The rAAV constructs were transfected into human retinal endothelial cells (HRECs). IGF-1R mRNA and protein levels were examined and the modified Boyden chamber assay used to examine ribozyme effects on cell migration. These constructs were injected intravitreally into mice to determine the effect of the ribozymes on retinal neovascularization in a mouse model of oxygen-induced retinopathy. RESULTS. Relative quantitative RT-PCR analysis showed that IGF-1R Rz1 reduced IGF-1R mRNA levels by 40% ± 10% (P = 0.003), and Western blot analysis showed a 41% ± 5% (P = 4.6 × 10-5) reduction of IGF-1R protein, confirming that this ribozyme reduces IGF-1R expression. IGF-1R Rz1 also reduced IGF-1-induced cell migration by 90% ± 5% (P = 2.9 × 10-9) showing that IGF-1R Rz1 reduces IGF-1R function in HRECs. IGF-1R Rz1 also reduced the amount of preretinal neovascularization by 65% ± 6% (P = 2.7 × 10-5), as measured by the average number of endothelial preretinal nuclei per section. CONCLUSIONS. These studies demonstrate that the IGF-1R ribozymes are effective at reducing the expression and function of the IGF-1R in vitro and in vivo. Therefore, the IGF-1R ribozymes are an effective method for studying the process of angiogenesis and may ultimately be effective as gene therapy tools for the reduction of pathologic retinal angiogenesis.

AB - PURPOSE. Insulin-like growth factor (IGF)-1 and its receptor (IGF-1R) are associated with abnormal retinal neovascularization. Ribozymes were designed that selectively decreased the expression of the IGF-1R and these ribozymes were tested in angiogenesis models in vitro and in vivo. METHODS. Two hammerhead ribozymes were designed that cleave the human IGF-1R mRNA. The ribozymes were cloned into recombinant adeno-associated viral vectors (rAAV). The rAAV constructs were transfected into human retinal endothelial cells (HRECs). IGF-1R mRNA and protein levels were examined and the modified Boyden chamber assay used to examine ribozyme effects on cell migration. These constructs were injected intravitreally into mice to determine the effect of the ribozymes on retinal neovascularization in a mouse model of oxygen-induced retinopathy. RESULTS. Relative quantitative RT-PCR analysis showed that IGF-1R Rz1 reduced IGF-1R mRNA levels by 40% ± 10% (P = 0.003), and Western blot analysis showed a 41% ± 5% (P = 4.6 × 10-5) reduction of IGF-1R protein, confirming that this ribozyme reduces IGF-1R expression. IGF-1R Rz1 also reduced IGF-1-induced cell migration by 90% ± 5% (P = 2.9 × 10-9) showing that IGF-1R Rz1 reduces IGF-1R function in HRECs. IGF-1R Rz1 also reduced the amount of preretinal neovascularization by 65% ± 6% (P = 2.7 × 10-5), as measured by the average number of endothelial preretinal nuclei per section. CONCLUSIONS. These studies demonstrate that the IGF-1R ribozymes are effective at reducing the expression and function of the IGF-1R in vitro and in vivo. Therefore, the IGF-1R ribozymes are an effective method for studying the process of angiogenesis and may ultimately be effective as gene therapy tools for the reduction of pathologic retinal angiogenesis.

UR - http://www.scopus.com/inward/record.url?scp=0042862923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0042862923&partnerID=8YFLogxK

U2 - 10.1167/iovs.03-0295

DO - 10.1167/iovs.03-0295

M3 - Article

VL - 44

SP - 4105

EP - 4113

JO - Investigative Ophthalmology and Visual Science

JF - Investigative Ophthalmology and Visual Science

SN - 0146-0404

IS - 9

ER -